Robert Langreth

1 week ago | news.bloomberglaw.com | Robert Langreth

Gilead Sciences Inc. said it won US approval for a drug to prevent HIV that only has to be given twice a year, making it a convenient new way to ward off infection in a wide range of people. In two big international studies published last year, the medicine demonstrated a powerful ability to avert HIV infection. With no vaccine on the horizon, the ultra-long acting shot has been hailed by activists as perhaps the best tool the world has so far to wipe out the virus.

1 week ago | nzherald.co.nz | Robert Langreth

Some 1.3 million people are infected with the HIV virus each year. Illustration / Getty ImagesGilead Sciences Inc said it won United States approval from Food and Drug Administration regulators for a drug to prevent HIV that only has to be given twice a year. That makes it a convenient new way to ward off infection in a wide range of people. In two big international studies published last year, the medicine demonstrated a powerful ability to avert HIV infection.

1 week ago | theday.com | Robert Langreth

We attempted to send a notification to your email address but we were unable to verify that you provided a valid email address. Please visit my profile to update your email address if you wish to receive notifications. Otherwise, disable notifications and hide this message.

1 week ago | financialpost.com | Robert Langreth

Article content(Bloomberg) — Gilead Sciences Inc. said it won US approval for a drug to prevent HIV that only has to be given twice a year, making it a convenient new way to ward off infection in a wide range of people. Sign In or Create an AccountArticle contentIn two big international studies published last year, the medicine demonstrated a powerful ability to avert HIV infection.

1 week ago | news.bloomberglaw.com | Robert Langreth

Gilead Sciences Inc. said it won US approval for a drug to prevent HIV that only has to be given twice a year, making it a convenient new way to ward off infection in a wide range of people. In two big international studies published last year, the medicine demonstrated a powerful ability to avert HIV infection. With no vaccine on the horizon, the ultra-long acting shot has been hailed by activists as perhaps the best tool the world has so far to wipe out the virus.